Evidence map›Paper›PMID 38548100›Full record

ArticleChest2024

Sarcoidosis Faculty Development: The Pipeline Is Running Dry.

Nicholas Arger, Michelle Sharp, Catherine Bonham, Divya Patel, Rohit Gupta, W Ennis James

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chest, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Americas Association of Sarcoidosis and other granulomatous disorders 2024 conference highlights.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Nicholas ArgerDivision of Pulmonary and Critical Care, University of California, San Francisco, San Francisco, CA.
Michelle SharpDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Catherine BonhamDepartment of Medicine, Division of Pulmonary and Critical Care and Sleep Medicine, University of Virginia, Charlottesville, VA.
Divya PatelDepartment of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL.
Rohit GuptaDepartment of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
W Ennis JamesDivision of Pulmonary and Critical Care Medicine, Susan Pearlstine Sarcoidosis Center of Excellence, Medical University of South Carolina, Charleston, SC. Electronic address: jamesw@musc.edu.
Johns Hopkins University · USMedical University of South Carolina · USTemple University · USUniversity of California, San Francisco · USUniversity of Florida · USUniversity of Virginia · US

Funding

Using high T-bet-expressing cells and Serum Chemokines as Indicators of Disease Severity in SarcoidosisK23HL156000 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARGER, NICHOLAS KOSTANDINOS · 2021 to 2025
$899k
Medication Adherence and Clinical Outcomes in SarcoidosisK23HL148527 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHARP, MICHELLE · 2021 to 2025
$886k
NHLBI NIH HHS K23 HL148527NHLBI NIH HHS K23 HL156000
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Faculty, MedicalHumansSarcoidosisStaff Development

Identifiers

PMID38548100
PMCPMC11904606
OpenAlexW4393189032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.